From: RECK is not an independent prognostic marker for breast cancer
 | Entire cohort (n = 940) | |||||
---|---|---|---|---|---|---|
 | Univariate | Multivariatea | ||||
Prognostic factor | HR | 95Â % CI | p-value | HR | 95Â % CI | p-value |
RECK (low vs. high) | 0.95 | 0.67–1.37 | 0.8 | 0.91 | 0.63–1.31 | 0.63 |
Age (continuous) | 1.01 | 1.01–1.02 | <0.01 | 1.01 | 1.01–1.02 | <0.01 |
Tumor size (continuous) | 1.05 | 1.02–1.07 | <0.01 | 1.03 | 1.01–1.06 | 0.02 |
Histological grading (3 vs. 1–2) | 1.27 | 1.14–1.40 | <0.01 | 1.24 | 1.11–1.38 | <0.01 |
TNM stage (IV vs. I–III) | 1.05 | 0.98–1.13 | 0.15 | 1 | 0.93–1.07 | 0.96 |
Nodal status (positive vs. negative) | 1.53 | 1.34–1.76 | <0.01 | 1.51 | 1.32–1.74 | <0.01 |
ER (positive vs. negative) | 0.88 | 0.77–1.01 | 0.08 | 0.96 | 0.81–1.13 | 0.6 |
PR (positive vs. negative) | 0.88 | 0.77–1.00 | 0.05 | 0.96 | 0.82–1.12 | 0.59 |
Her2 (positive vs. negative) | 1.22 | 1.01–1.48 | 0.04 | 1.01 | 0.82–1.25 | 0.91 |